Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,677.8
24.8 (0.94%)

 

  • STI Straits Times Index
    2,677.8
    24.8 (0.94%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.6
    18.9 (1.22%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,223.1
    850.0 (3.35%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,313.6
    160.8 (5.10%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,713.9
    407.4 (1.83%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,995.2
    21.5 (0.43%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 765.0M
  • Value: 472.0M
  • Rise: 221
  • Fall: 60
  • Unch: 527

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.120+0.005
Medtecs Intl0.585+0.085
Rex Intl0.184+0.004
LionGold0.002-
Synagie0.197+0.006
Yoma Strategic0.320+0.005
MDR0.001-
AnAn Intl0.070+0.006
KOP0.068+0.007
Spackman0.009-0.001

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

PROFOUND MED CORP PROFOUND MEDICAL CORP
Updated on 02 Jul 2020 (End of trading day)
Last (USD): 17.490 Change: -0.100 High: 18.000 Remarks: -
Change (%): -0.57 Low: 17.000
Open 17.600 Yesterday's Close 17.59
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 71,043 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.94622 Trailing EPS (USD) e -0.97625 NAV (USD) b 3.2844
PE a - Trailing PE f - Price / NAV b 5.3252
Dividend (USD) d - Cash In Hand (USD) g 2.7041 Issued & Paid-up Shares c 16,082,600
Dividend Yield (%) d - Price / Cash In Hand g 6.468 Treasury Shares h -
Market Cap (M) 281.285 Enterprise Value (M) 239.443
Piotroski F Score 3 Exchange Code PROF Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 81.0
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 11 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Oct 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference PROFOUND MED CORP NASDAQ 281.285 - - 5.3252 -
Industry Medical Specialties NASDAQ 2,360.614 404.083 111.599 8.1515 0.038
Local Peer INTUITIVE SURGICAL INC NASDAQ 67,694.417 49.079 48.831 7.9578 -
Local Peer DEXCOM INC NASDAQ 37,598.405 371.894 254.215 40.2337 -
Local Peer IDEXX LABORATORIES INC NASDAQ 28,432.171 66.474 65.082 264.0480 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 22,048.099 49.795 11.671 7.7281 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 21,829.665 67.230 164.819 10.3111 -
Local Peer HOLOGIC INC NASDAQ 14,939.799 - 24.245 7.1616 -
Local Peer INSULET CORPORATION NASDAQ 13,235.049 1,140.920 2,567.918 224.3279 -
Local Peer MASIMO CORPORATION NASDAQ 12,539.620 63.907 59.331 10.0054 -
Local Peer ABIOMED INC NASDAQ 11,884.435 58.541 58.541 11.1542 -
Local Peer DENTSPLY SIRONA INC NASDAQ 9,678.954 36.816 115.501 2.0648 0.857
Local Peer QUIDEL CORP NASDAQ 9,535.453 130.764 107.972 15.7559 -
Local Peer BRUKER CORPORATION NASDAQ 6,400.545 32.457 36.182 6.9905 0.385
Other Local Peers NOVOCURE LTD (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), NEOGEN CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), NUVASIVE INC (NASDAQ), STAAR SURGICAL CO (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), LIVANOVA PLC (NASDAQ), INARI MEDICAL INC (NASDAQ), ATRICURE INC (NASDAQ), CAREDX INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), ZYNEX INC (NASDAQ), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SI BONE INC (NASDAQ), AXOGEN INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), VIEWRAY INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), IRADIMED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MISONIX INC (NASDAQ), RTI SURGICAL HOLDINGS INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CUTERA INC (NASDAQ), DERMTECH INC (NASDAQ), SIENTRA INC (NASDAQ), TELA BIO INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), CELSION CORPORATION (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), BIOMERICA INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), IMMUCELL CORP (NASDAQ), NEOVASC INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEURONETICS INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), ELECTROCORE INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AETHLON MEDICAL INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), AVINGER INC (NASDAQ), ENDOLOGIX INC (NASDAQ), CYANOTECH CORP (NASDAQ), DIGIRAD CORP (NASDAQ), DYNATRONICS CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), CANCER GENETICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 163,141.035 44.501 46.098 5.3988 1.426
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 144,508.621 39.099 39.386 5.0600 0.210
Global Peer DANAHER CORP NYSE 127,293.757 51.147 46.508 4.3216 0.372
Global Peer MEDTRONIC PLC NYSE 124,955.508 26.092 26.092 2.4628 2.318
Global Peer BECTON DICKINSON & CO NYSE 69,460.859 64.197 76.331 3.3157 1.199
Global Peer STRYKER CORP NYSE 68,945.862 33.099 31.860 5.2570 1.160
Global Peer BOSTON SCIENTIFIC CORP NYSE 50,548.467 10.755 11.791 3.6619 -
Global Peer BAXTER INTERNATIONAL INC NYSE 44,375.588 44.331 43.463 5.7638 0.970
Global Peer EDWARDS LIFESCIENCES CORP NYSE 42,874.552 40.954 38.702 10.9904 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 42,666.250 32.665 32.665 3.0174 1.923
Other Global Peers ALCON AG (NYSE), RESMED INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), STERIS PLC (NYSE), HARTA (Bursa), TOPGLOV (Bursa), Top Glove (SGX), WATERS CORP (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), WEIGAO GROUP (HKEx), PERKINELMER INC (NYSE), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), KANGJI MEDICAL (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), NEVRO CORP (NYSE), AK MEDICAL (HKEx), ENVISTA HOLDINGS CORPORATION (NYSE), SUPERMX (Bursa), PEIJIA-B (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), EBOS GROUP (ASX), CONMED CORP (NYSE), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), KDL MEDICAL (HKEx), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), LIFETECH SCI (HKEx), VAPOTHERM INC (NYSE), CIRC (HKEx), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), PW MEDTECH (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), GOLDEN MEDITECH (HKEx), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ALPHA PRO TECH (NYSE American), INVACARE CORP (NYSE), RETRACTABLE TECHNOLOGIES INC (NYSE American), Medtecs Intl (SGX), UG Healthcare (SGX), MODERN DENTAL (HKEx), VINCENT MED (HKEx), ATOMO DIAGNOSTICS LIMITED (ASX), ELECTROMED INC (NYSE American), VOLITIONRX LIMITED (NYSE American), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), MILESTONE SCIENTIFIC INC (NYSE American), LKL (Bursa), Biolidics (SGX), SDI LTD (ASX), IMPEDIMED LIMITED (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), DIMERIX LTD (ASX), ONCOCYTE CORP (NYSE American), COMPUMEDICS (ASX), RESONANCE HEALTH LTD (ASX), KELFRED (HKEx), RESPIRI LTD (ASX), OVENTUS MEDICAL LTD (ASX), Yunnan Energy (SGX), MICRO-X LTD (ASX), LBT INNOVATIONS LTD (ASX), IMPRESSION HEALTHCARE LIMITED (ASX), METALICITY LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), USCOM LTD (ASX), LIFE HEALTHCARE (HKEx), XTANT MEDICAL HLDGS INC (NYSE American), IMAGION BIOSYSTEMS LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE), OPTISCAN IMAGING (ASX), CARDIEX LTD (ASX), Annica (SGX), ADHERIUM LIMITED (ASX), ANALYTICA (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), DORSAVI LTD (ASX), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+1.410
+8.77 %
10 Days -+4.040
+30.04 %
20 Days -+4.160
+31.21 %
Medium Term Return 3 Months -+7.180
+69.64 %
6 Months -+7.300
+71.64 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 6.530 - 20.602 Change From 1 Year Low +10.960 % Change From 1 Year Low (%) +167.84
Change From 1 Year High -3.112 % Change From 1 Year High (%) -15.11
2 Years Range 6.530 - 20.602 Change From 2 Years Low +10.960 % Change From 2 Years Low (%) +167.84
Change From 2 Years High -3.112 % Change From 2 Years High (%) -15.11
5 Years Range 6.530 - 20.602 Change From 5 Years Low +10.960 % Change From 5 Years Low (%) +167.84
Change From 5 Years High -3.112 % Change From 5 Years High (%) -15.11
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
02 Jul 2020 17.600 18.000 17.000 17.490 71,043 -
01 Jul 2020 17.050 17.650 16.370 17.590 56,026 -
30 Jun 2020 16.250 17.449 15.920 16.940 121,457 -
29 Jun 2020 16.250 16.250 15.335 16.080 64,608 -
26 Jun 2020 14.500 16.250 14.005 16.080 107,460 -
25 Jun 2020 14.380 14.970 14.060 14.360 38,257 -
24 Jun 2020 14.680 15.000 13.710 14.650 59,937 -
23 Jun 2020 13.350 15.970 13.350 15.130 141,221 -
22 Jun 2020 13.240 13.500 12.900 13.450 24,787 -
19 Jun 2020 12.670 13.250 12.444 13.030 49,991 -
18 Jun 2020 12.459 12.610 12.350 12.470 14,090 -
17 Jun 2020 12.400 12.460 12.195 12.450 11,345 -
16 Jun 2020 12.320 12.730 12.260 12.400 24,775 -
15 Jun 2020 12.160 12.400 11.650 12.130 25,193 -
12 Jun 2020 12.350 13.090 12.090 12.160 33,288 -
11 Jun 2020 12.500 13.110 12.140 12.460 52,092 -
10 Jun 2020 13.370 13.870 12.630 12.710 29,334 -
09 Jun 2020 13.300 13.730 12.810 13.350 31,617 -
08 Jun 2020 12.990 13.610 12.840 13.330 48,323 -
05 Jun 2020 12.620 13.120 12.300 12.850 63,959 -
04 Jun 2020 12.720 12.770 12.350 12.570 43,086 -
03 Jun 2020 12.300 12.500 12.180 12.500 16,387 -
Summary
Current 2 Weeks
(19 Jun 2020 to 02 Jul 2020)
12.670 18.000 12.444 17.490 734,787 -
Previous 2 Weeks
(05 Jun 2020 to 18 Jun 2020)
12.620 18.000 12.300 12.470 334,016 -
4 Weeks from
(07 May 2020 to 04 Jun 2020)
12.780 18.000 12.420 12.570 1,137,091 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.